Nuburu (BURU) Secures Strategic $65M Funding

NUBURU, Inc. (NYSE American: BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced a comprehensive funding program of approximately $65 million, including $15 million of direct investment and $50 million equity line of credit. This funding represents a pivotal moment for NUBURU, enabling us to accelerate commercialization with predictable access to capital.

Investment Summary:

On October 1, 2024, NUBURU, Inc. (the “Company”) entered into a master transaction terms agreement (the “Master Agreement”) with Liqueous LP, a Delaware limited partnership (the “Investor”) pursuant to which, the Company and the Investor established a strategic financing framework for short-term and long-term financing for the Company. The Master Agreement provides for: (i) an immediate capital infusion from the Investor of $3 million at current market price, (ii) subsequent weekly capital infusions of $1,250,000 at market price until an additional $10 million has been invested; (iii) the acquisition and conversion of certain outstanding notes; (iv) an adjustment to current market price of certain outstanding pre-funded warrants held by the Investor having a current cash value of approximately $2.2 million; and (v) the implementation of a $50 million equity line of credit (the “ELOC”) pursuant to which the Company may require the Investor to purchase common stock from time-to-time in the amounts and for the prices determined in accordance with the terms of the ELOC which includes an optional advancement of $2.5M through a convertible note with an 8% annual interest rate and with a conversion rate at a 10% discount to the lower of the previous day’s closing price or the prior five-day average. No issuances pursuant to the financing plan will be made to the extent such issuances would: (a) cause the Investor to hold greater that 4.99% at any time; or (b) result in the issuance of greater than 19.9% of the Company’s outstanding common stock, unless any stockholder approval that is required under NYSE American rules is first obtained.

Strategic Partnerships and Technology Leadership:

Our innovative blue laser technology is protected by 233 patents and includes both public and private sector applications. Our strategic partnerships include past and active contracts with NASA and the U.S. Air force all which validate our innovations and underscore the value of our technology.

Long-Term Growth Alignment:

This financing provides both an immediate capital infusion and access to a long-term capital facility to support our strategic goal of long-term, sustainable growth. These infusions, combined with our robust IP portfolio, position us to achieve commercialization and continue to advance and expand our IP portfolio.

You May Also Be Interested In

• Chemours reaches $450M settlement over PFAS pollution at four sites
• Newmark hires ex-CBRE advisor to lead consulting group
• Freshpet co-founder Morris to step back as Baty takes president role